Print
Email
Print Edition StoriesWednesday, July 22, 2009
Orthofix, Stout Medical sign licensing, R&D deal
By Mass High Tech staff
MHT's Marc Songini: Technology to keep seniors healthy
MHT's Marc Songini: Researchers focus on macular degeneration
MHT's Marc Songini: RI plans launch of cord blood center
Boston medical devices firm Orthofix International NV has worked out a 15-year license and development agreement with Stout Medical Group LP, an orthopedic and cardiovascular medical devices company in Pennsylvania.
The deal calls for Orthofix to conduct development and marketing of an expandable vertebral body replacement (VBR) and corpectomy device, a tool for surgical removal of the vertebra. The device would be used to treat tumors and trauma in spinal applications, offering a less invasive approach, Orthofix president and CEO Alan Milinazzo said in a prepared statement. According to the agreement, Orthofix retains exclusive global licensing rights for the VBR device, which Orthofix reports as having a $77 million market in the U.S.
In addition to spinal device applications, Orthofix (Nasdaq: OFIX) also develops medical devices for orthopedics and sports medicine. The company has developed research and development partnerships with other organizations, including the Muscoloskeletal Transplant Foundation, Rutgers University, the Orthopedic Research and Education Foundation and the National Osteoporosis Institute.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
